I'm LongbridgeAI, I can summarize articles.Aktis Oncology insiders sold shares worth over $2.8 million on July 8, 2026. Chief Medical Officer Akos Czibere and Chief Operating Officer Shulamit Ron-Bigger each sold approximately $1.39 million in common stock across three transactions. Following these sales, neither officer directly owns any common stock in the company. The transactions were reported via SEC Form 4 filings.
Czibere Akos, an officer serving as Chief Medical Officer, sold common stock on July 8, 2026 with reported weighted average prices of $27.1273, $27.9521 and $28.7078 per share for three separate disposals and a total reported sale amount of $1,388,701; following the reported transactions the reporting person no longer directly owns common stock of Aktis Oncology.
Ron-Bigger Shulamit, an officer serving as Chief Operating Officer, sold common stock in three transactions on July 8, 2026 with reported weighted average prices of $27.1317, $27.9379 and $28.7476 per share and a total reported sale amount of $1,387,557; following the reported transactions the reporting person no longer directly owns any common stock of Aktis Oncology.
| Reporter Name | Relationship | Type | Amount | SEC Filing |
|---|---|---|---|---|
| Czibere Akos | Chief Medical Officer | Sell | $1,388,701 | Form 4 |
| Ron-Bigger Shulamit | Chief Operating Officer | Sell | $1,387,557 | Form 4 |